Joghem van Loghem
Dutch immunologist
Joghem van Loghem (1914–2005) was a prominent Dutch immunologist known for his pioneering work in the field of immunogenetics and blood transfusion. His contributions significantly advanced the understanding of human leukocyte antigens (HLA) and their role in transplantation and autoimmune diseases.
Early Life and Education[edit | edit source]
Joghem van Loghem was born in 1914 in the Netherlands. He pursued his medical education at the University of Amsterdam, where he developed an interest in immunology and hematology. After completing his medical degree, van Loghem continued his studies, focusing on the emerging field of immunogenetics.
Career[edit | edit source]
Van Loghem began his career at the Central Laboratory of the Netherlands Red Cross Blood Transfusion Service in Amsterdam. Here, he worked under the guidance of renowned scientists and quickly established himself as a leading figure in the study of blood groups and antigen-antibody reactions.
Contributions to Immunogenetics[edit | edit source]
Van Loghem's research was instrumental in the discovery and characterization of the HLA system, which is crucial for organ transplantation compatibility. His work helped to elucidate the genetic basis of HLA antigens and their role in immune response regulation. This research laid the groundwork for safer and more effective transplantation procedures.
Blood Transfusion Research[edit | edit source]
In addition to his work on HLA, van Loghem made significant contributions to the field of blood transfusion. He developed methods to improve the safety and efficacy of blood transfusions, particularly in the context of hemolytic disease of the newborn and autoimmune hemolytic anemia.
Legacy[edit | edit source]
Joghem van Loghem's work has had a lasting impact on the fields of immunology and transfusion medicine. His research not only advanced scientific understanding but also improved clinical practices, leading to better patient outcomes. Van Loghem was a respected educator and mentor, influencing a generation of scientists and clinicians.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
